Iain McGill joins EUSA Pharma
This article was originally published in Scrip
EUSA Pharma (UK/US), a speciality pharmaceutical company focused on oncology, pain control and critical care, has named Iain McGill president, Europe and International. The appointment marks the completion of EUSA's executive management team and the company’s commercial infrastructure. Mr McGill joins from Wyeth Pharmaceuticals, where he was vice-president and global manager for the company’s transplantation business. Previously, he was the head of Novartis’s transplantation, immunology and infectious diseases business unit in Canada, and was a global brand director at Novartis’s headquarters in Switzerland.